Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Molecular Neuroscience : MN|August 30, 2022
DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma PatientsYulong Jia, Zhendong Liu, Xingbo Cheng, et al.Frontiers in Oncology|January 3, 2022
ELK3: A New Molecular Marker for the Diagnosis and Prognosis of GliomaZhendong Liu, Zhishuai Ren, Cheng Zhang, et al.Cell Cycle (Georgetown, Tex.)|May 22, 2020
Abnormally high expression of HOXA2 as an independent factor for poor prognosis in glioma patientsZhendong Liu, Fei Shen, Hongbo Wang, et al.Frontiers in Genetics|September 13, 2021
ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of GliomaZhendong Liu, Xiaoyu Lian, Xiuru Zhang, et al.Molecular and Clinical Oncology|July 19, 2021
Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic valueBo Zhang, Jiawei Yao, Xiaoyu Lian, et al.Journal of Cellular and Molecular Medicine|December 25, 2021
ITGB3BP is a potential biomarker associated with poor prognosis of gliomaZhendong Liu, Binfeng Liu, Lu Bian, et al.Peerj|February 22, 2021
Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patientsJialin Wang, Zhendong Liu, Cheng Zhang, et al.Cell Cycle (Georgetown, Tex.)|July 19, 2022
High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomesZhenghong Yu, Zhendong Liu, Xiaoyu Lian, et al.Signal Transduction and Targeted Therapy|May 20, 2025
PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcomaBinfeng Liu, Wei Li, Wenchao Zhang, et al.Cancer Medicine|July 15, 2021
Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cellsZhendong Liu, Hongbo Wang, Yulong Jia, et al.Pageof 5